Inspections, Compliance, Enforcement, and Criminal Investigations
Prodigy Diabetes Care, LLC - Close Out Letter 4/10/14
Department of Health and Human Services
|Food and Drug Administration|
|Atlanta District Office|
60 Eighth Street N.E.
Atlanta, GA 30309
April 10, 2014
Richard F. Admani
Chief Operating Officer
Prodigy Diabetes Care, LLC
2701-A Hutchison McDonald Road, Suite A
Charlotte, NC 28269
Dear Mr. Admani:
The Food and Drug Administration has completed an evaluation of your firm's corrective actions in response to our Warning Letter, 13-ATL-10, dated February 22, 2013. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Atlanta District Director